Skip to Main Content

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Conditions

Children's Health | Immune System | Arthritis

What is the purpose of this trial?

Brief Summary:

Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.

  • Trial with
    Duke University
  • Start Date
    07/25/2018
  • End Date
    06/30/2028

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/15/2021
  • Study HIC
    #2000023073REG